🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Protocol V503-021 is a long-term follow-up study of the V503-001 base study...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2016-01-22
Trial ID
NCT02653118
The purpose of this study is to determine the safety of and immune response...
Status
Completed
Location
San Francisco Vaccine and Prevention CRS
Start Date
TBD
Trial ID
NCT00119873
Treatments Being Tested
This is a pilot trial designed to assess safety and immunogenicity of a mul...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2000-11
Trial ID
NCT00579423
Treatments Being Tested
The objective of this study is to evaluate the safety and immunogenicity of...
Status
Completed
Location
Paratus Clinical
Start Date
2025-03-19
Trial ID
NCT06850051
Treatments Being Tested
RATIONALE: Vaccines may help the body build an effective immune response to...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2008-09
Trial ID
NCT00784524
Treatments Being Tested
The primary objectives of this study are to evaluate the safety and reactog...
Status
Active Not Recruiting
Location
Accel Research Sites - Achieve Clinical Research
Start Date
2024-09-24
Trial ID
NCT06592794
This is a phase Ib study with a safety lead-in (n = 6 per arm) evaluating c...
Status
Recruiting
Location
Portland Providence Medical Center
Start Date
2021-08-05
Trial ID
NCT04470024
Treatments Being Tested
The purpose of this clinical trial is to learn about a pneumococcal vaccine...
Status
Completed
Location
Indago Research & Health Center, Inc
Start Date
2023-04-19
Trial ID
NCT05831124
BEATRIX (group B strEptococcus mATeRnal and Infant VaX study) The purpose o...
Status
Recruiting
Location
Center for Research in Women's Health
Start Date
2025-08-25
Trial ID
NCT07160244
The purpose of the Part A Phase 1 of this study is to evaluate the safety, ...
Status
Active Not Recruiting
Location
ARK Clinical Research, LLC
Start Date
2023-08-25
Trial ID
NCT05992935